Slate Path Capital’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.82M | Hold |
|
|||||
|
2024
Q2 | $2.98M | Hold |
|
|||||
|
2024
Q1 | $4.54M | Hold |
|
|||||
|
2023
Q4 | $6.34M | Hold |
|
|||||
|
2023
Q3 | $5.53M | Hold |
|
|||||
|
2023
Q2 | $8.77M | Hold |
|
|||||
|
2023
Q1 | $8.58M | Hold |
|
|||||
|
2022
Q4 | $6.85M | Buy |
|
|||||
|
2022
Q3 | $3.31M | Hold |
|
|||||
|
2022
Q2 | $3.69M | Hold |
|
|||||
|
2022
Q1 | $7.24M | Hold |
|
|||||
|
2021
Q4 | $16.8M | Hold |
|
|||||
|
2021
Q3 | $21.6M | Hold |
|
|||||
|
2021
Q2 | $17.3M | Hold |
|
|||||
|
2021
Q1 | $18.1M | Hold |
|
|||||
|
2020
Q4 | $18.6M | Hold |
|
|||||
|
2020
Q3 | $22.3M | Buy |
|
|||||
|
2020
Q2 | $21.3M | Hold |
|
|||||
|
2020
Q1 | $12.4M | Sell |
|
|||||
|
2019
Q4 | $14.1M | Hold |
|
|||||
|
2019
Q3 | $7.5M | Buy |
|